-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Maintains Outperform on Staar Surgical, Lowers Price Target to $37

Benzinga·08/13/2026 12:58:54
语音播报
Wedbush analyst Michael Piccolo maintains Staar Surgical (NASDAQ:STAA) with a Outperform and lowers the price target from $40 to $37.